Programme

PROGRAMME

INTERACTIVE DETAILED PROGRAMME IS NOW AVAILABLE HERE

Friday 23 October 2020, 16:00 - 21:00 CET

16:00 - 16:04	Welcome by the ESSO President, Tibor Kovacs, UK
16:04 - 16:05	Sponsors´ pitches
16:05 – 16:50	Impact of COVID-19 on cancer surgical care (cross-specialty session) Chair: Tibor Kovacs, UK Co-chair: James Howe, USA Moderator: Delia Cortes Guiral, SP COVID-19 burden in High Income Countries (HIC) and how it affected surgical care for cancer patients - Speaker: Marco Montorsi, IT COVID-19 burden in Low and Middle Income Countries (LMIC) and how it affected surgical care for cancer patients - Speaker: Dr. SVS Deo, IN COVIDSurg-Cancer: Improving safety of surgery for patients undergoing cancer surgery during the SARS-CoV-2 pandemic - Speaker: James Glasbey, Elizabeth Li (on behalf of the CovidSurg Collaborative) The SWALIS-2020 new model to prioritize elective surgery under the COVID-19 pandemic pressure Speaker: Roberto Valente, IT Open panel discussion
16:50 – 17:20	Sysmex Satellite Symposium - Discover optimised techniques for lesion localisation, sentinel node biopsy and TAD Magseed® as long-term marker for target lymph nodes during neoadjuvant therapy – first experiences and perspectives – Speaker: Marc Thill, DE Using Magtrace® and Magseed® to improve the care process and comfort for breast cancer patients and their treatment providers – Speaker: Maria Margarete Karsten, DE
17:20 - 18:20	Breast session: Tailoring breast cancer surgical treatments in the era of de-escalation Chair: Isabel Teresa Rubio, SP Co-chair: Giacomo Montagna, CH Moderator: Emily Postma, NL Surgical de-escalation in Her2 positive breast cancer patients. The ideal subtype - Speaker: Reimer Toralf, DE Techniques for excising the marked nodes after neoadjuvant treatment. Will any become the gold standard? - Speaker: Tanir M. Allweis, IL Neoadjuvant chemotherapy in the era of immunotherapy: the future is bright - Speaker: Carmen Criscitiello, Milan, IT Tumour-stroma ratio is associated with Miller-Payne grading system and pathological response to neoadjuvant chemotherapy in HER2-negative breast cancer - Speaker: Sophie Hagenaars, NL Can machine learning be used to reduce overtreatment of the axilla in breast cancer? Results from a retrospective cohort study - Speaker: Felix Jozsa, UK FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe - Speaker: Madeleine Tilanus-Linthorst, NL Open panel discussion
18:20 – 18:35	Sirius Medical Systems Satellite Workshop Moderator: Jan Willem Beijer Moderator: Massimiliano Malloni
18:35 – 19:20	HPB updates Chair: Chandra Are, USA Co-chair: Hassan Malik, UK Moderator: Florian Primavesi, AT Current status on surgical management of Oligometastatic pancreas cancer - Speaker: Kevin Conlon, IE Current landscape of MIS in HPB surgery - Speaker: Daniel Anaya, US Impact of AI on HPB surgery - Speaker: Benoît Gallix, FR Hepatic and extrahepatic colorectal metastases have discordant responses to chemotherapy: Pathology data from patients undergoing simultaneous resection of multiple tumor sites - Speaker: Pio Corleone, IT Open panel discussion
19:20 – 19:50	Agendia Satellite Symposium Moderator: Laura van ‘t Veer, NL How does genomic profiling impact your breast cancer surgery? – Speakers: Emiel J.T. Rutgers, Isabel Teresa Rubio, SP
19:50 – 20:50	Hot Topics in the therapy of Colorectal Cancer Chair: Geerard Beets, NL Co-chair: Isacco Montroni, IT Moderator: Laura Lorenzon, IT Total neoadjuvant therapy in rectal cancer - Speaker: C. J. van de Velde, NL TAMIS (Video presentation) - Speaker: Sam Atallah, USA Immunotherapy in colorectal cancer - Speaker: Myriam Chalabi, NL Malignant features present in pre-treatment lateral pelvic lymph nodes in low rectal cancer predict distant metastases and survival, but not local recurrences Speaker: Hidde Kroon, AU Patterns of failure and outcomes of rectal cancer patients who had a positive pathological circumferential resection margin (pCRM) - Speaker: Swapnil Patel, IN Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Limited Peritoneal Metastasis. The PSOGI International Collaborative Registry - Speaker: Alvaro Arjona, SP Open panel discussion
20:50 – 20:55	Closing remarks, Domenico D’Ugo, IT

Saturday 24 October 2020, 09:00 - 13:05 CET

09:00 - 09:05	Welcome by the ESSO President-Elect, Domenico D’Ugo, IT
09:05 – 09:50	Robotic surgery for Abdominal Cancers: How far can we go? Chair: Han-Kwang Yang, KR Co-Chair: Andreas Brandl, PT Robotics for Gastric Cancer - Speaker: Masnori Terashima, JP Robotics in lower GI - Speaker: Amjad Parvaiz, UK Robotics in HPB - Speaker: Johann Pratschke, DE Robotic complete mesocolic excision with central vascular ligation for right colonic tumours—technical notes and oncological outcomes compared to a propensity score-matched laparoscopic group - Speaker: Samuel Stefan, UK Open panel discussion
09:50 – 10:20	S.I.T. Symposium / IOeRT Clinical Guidelines & Applications and Groundbreaking Technological Developments Introduction of IOeRT principles and current applications in surgical oncology – Speakers: Felipe Calvo Manuel, Isabel Teresa Rubio, SP, Philip Poortmans, FR
10:20 - 11:05	Upper GI session Chair: William Allum, UK Co-Chair: Beate Rau, DE Moderator: Karol Polom, PL KLASS-02 for Gastric Cancer - Speaker: Sang-Uk Han, KR Complications in Upper GI surgery - Speaker: Gian Luca Baiocchi, IT Trial Update - Immunotherapy - Speaker: Elizabeth Smyth, UK 10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial) - Speaker: Ben Eyck, NL Open panel discussion
11:05 – 11:35	Hologic Symposium Moderator: Bob Martins, FR Wire-free Localization for surgery of non-palpable breast lesions with LOCalizer radiofrequency identification (RFID) tags : our experience from the first 150 cases – Speaker: Robert Milligan, UK
11:35 – 12:05	Medical nutrition along the surgical oncology patient’s journey (cross specialty session) Session supported by an unrestricted grant from ESSO corporate member Nutricia Chair: Sergio Sandrucci, IT Co-chair: Wim Ceelen, BE Moderator: Yvonne Schrage, NL Perioperative Nutritional Support of oncologic surgical Patients in the Age of ERAS - Speaker: Luca Nespoli, IT Clinical Value of Nutritional Status in Cancer surgery: can Disease Progression and Prognosis be affected? - Speaker: Alessandro Laviano, IT Open panel discussion
12:05 – 12:20	Break
12:20 – 13:05	Impact of COVID-19 on surgical and surgical oncology education (cross-specialty session) Chair: Domenico D’Ugo, IT Co-chair: Douglas Tyler, USA Moderator: Nada Santrac, SB Impact of COVID-19 on educating the next generation of surgical oncologists in Low and Middle Income Countries (LMIC) - Speaker: Pankaj Kumar Garg, IN Future of Surgical Oncology in the era of COVID-19 - Speaker: Douglas Tyler, USA Training in Surgical Oncology during & beyond COVID19 pandemic - Speaker: Jim Khan, UK Open panel discussion
13:00 – 13:05	Take home message, Domenico D’Ugo, IT